+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

USA Solid Tumor Therapeutics Market Outlook to 2028 - Product Thumbnail Image

USA Solid Tumor Therapeutics Market Outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
From
Lichen Planus- Pipeline Insight, 2025 - Product Thumbnail Image

Lichen Planus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Monoamine Oxidase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Monoamine Oxidase Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Acromegaly Market Report 2025 - Product Thumbnail Image

Acromegaly Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Diabetic Retinopathy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Diabetic Retinopathy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
GLP-1 Receptor Agonist Market - Global Forecast 2025-2030 - Product Thumbnail Image

GLP-1 Receptor Agonist Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
From
From
From
DNA Repair Drugs: Global Markets - Product Thumbnail Image

DNA Repair Drugs: Global Markets

  • Report
  • February 2022
  • 112 Pages
  • Global
From
Loading Indicator